Cite

HARVARD Citation

    Li, J. et al. (2020). Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination. Medicine. 99 (43), p. . [Online]. 
  
Back to record